Cholesterol News

High Cholesterol In Your 40s Increases Risk Of Alzheimer's Disease

Mon, 23 Jun 2008 13:00:16 GMT

People with high cholesterol in their early 40s are more likely to develop Alzheimer's disease than those with low cholesterol, according to research that will be presented at the upcoming American Academy of Neurology 60th Anniversary Annual Meeting in Chicago, April 12-19, 2008.

Full text

Tredaptive Recommended For EU Approval For The Treatment Of Mixed Dyslipidaemia And Primary Hypercholesterolaemia

Mon, 23 Jun 2008 13:00:15 GMT

Merck Sharp & Dohme Limited (MSD) announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for 'Tredaptive'™

Full text

LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase II Clinical Program

Mon, 23 Jun 2008 13:00:15 GMT

LifeCycle Pharma A/S (OMX:LCP) announced positive results from the company's Phase II clinical program with LCP-AtorFen, a fixed-dose combination product of atorvastatin and fenofibrate for the treatment of mixed dyslipidemia.

Full text

Transporting Your Apolipoproteins Testing To The Next Level

Mon, 23 Jun 2008 13:00:14 GMT

Randox produces high quality apolipoprotein tests for the diagnosis, monitoring and research of cardiovascular disease and related conditions.

Full text

New Blood Test Reveals Risk For Metabolic Syndrome

Mon, 23 Jun 2008 13:00:13 GMT

University of Minnesota researchers have discovered that people with high oxidation levels of the low-density lipoprotein (LDL) particle that carries cholesterol throughout the blood are much more likely to develop metabolic syndrome - which can lead to a considerably increased risk of developing heart disease.

Full text

Pfizer And Ranbaxy Settle Lipitor Patent Litigation Worldwide

Mon, 23 Jun 2008 13:00:12 GMT

Pfizer Inc announced that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd.

Full text

Incyte's Selective Oral Inhibitor Of 11beta-HSD1 Demonstrates Improvements In Insulin Sensitivity And Lowers Cholesterol Levels In Type 2 Diabetics

Sun, 22 Jun 2008 09:40:03 GMT

Incyte Corporation (Nasdaq:INCY) announced clinical results presented today at the American Diabetes Association 68th Scientific Sessions of its Phase IIa trial of INCB13739, an orally bioavailable inhibitor of the 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) enzyme.

Full text

Lower Blood Pressure Linked To Statins

Sat, 21 Jun 2008 06:20:05 GMT

An article published in the Archives of Internal Medicinereports that statins - medications that are usually prescribed to lowerblood cholesterol levels - may also lower blood pressure.

Full text

Two Merck Medicines Recommended For Approval In The European Union

Sat, 21 Jun 2008 06:20:04 GMT

Merck & Co., Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended two medicines for marketing approval in the European Union (EU).

Full text

PanGenex PGXC Introduces LIPIDEME trade; To Lower Cholesterol Naturally And Increase Cardiovascular Health

Sat, 21 Jun 2008 06:20:03 GMT

PanGenex Corporation (Pink Sheets: PGXC) announces the product launch of LIPIDEME™ , an all-natural nutraceutical formulated with scientifically proven ingredients and the first product on the market to combine the triglyceride-lowering power of Omega-3 fatty acids with the cholesterol lowering ability of phytosterols and tocotrienols - plus the free-radical fighting capacity of Coenzyme Q10 (CoQ10).

Full text